YPO Welcomes 2018 YPO Innovation Week Sponsors
DALLAS, April 24, 2018 (GLOBE NEWSWIRE) -- YPO, the world's premier leadership organization of chief executives, announced today that Techstars has joined as a gold sponsor and Geniecast, Emplify and Telluride are silver sponsors of the 2018 YPO Innovation Week.
YPO Innovation Week sponsors offer valuable insight, key connections and respected expertise that made the world's largest and most impactful innovation initiative possible.
"YPO Innovation Week brings together some of the most innovative and disruptive leaders around the world," said YPO CEO Scott Mordell. "We are so pleased to partner with these prestigious and forward-thinking organizations and businesses to help elevate the week's experiences for our members and take innovation to the next level."
During the week of 7-11 May 2018, YPO will host innovation events across the globe from Sydney, Australia to London, England; Tel Aviv, Israel to New York, New York, USA; Santo Domingo, Dominican Republic to Palo Alto, California, USA and Nairobi, Kenya, and more.
The mission of YPO Innovation Week is to drive innovation and transformation across a diverse range of industries and sectors through signature events, live interactive video casts and livestream events across more than 30 countries. Business leaders and pioneering thinkers will engage in a weeklong forum discussing the most important innovations affecting business today, including augmented and virtual reality, vehicle technology, digital imaging, wearables, smart home, sensors and more.
"We welcome these prestigious partners and their participation in the 2018 YPO Innovation Week," said YPO Innovation Week Chair Keith Alper. "With their support, we will truly be able to overturn conventional thinking and inspire business leaders to accelerate what's next."
Techstars is featuring Techstars Founders who will deliver pitches at several YPO Innovation Week events, including the Global FinTech Summit, the World Technology Summit and the NYSE Closing Bell event.
Geniecast is hosting digital events throughout YPO Innovation Week via two-way video broadcast.
Emplify's CEO Santiago Jaramillo, a YPO member, will present on the future of work at the Silicon Valley Summit and World Technology Summit.
Telluride is hosting a virtual reality space at the Silicon Valley Summit and providing an exclusive prize package for YPO Global Innovation Award finalists.
The premier leadership organization of chief executives in the world.
YPO is the global platform for chief executives to engage, learn and grow. YPO members harness the knowledge, influence and trust of the world's most influential and innovative business leaders to inspire business, personal, family and community impact.
Today, YPO empowers more than 25,000 members in more than 130 countries, diversified among industries and types of businesses. Altogether, YPO member-run companies employ more than 16 million people and generate USD6 trillion in annual revenues.
Leadership. Learning. Lifelong. For more information, visit YPO.org.
Techstars is the worldwide network that helps entrepreneurs succeed. Techstars founders connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporations to grow their companies. Techstars operates four divisions: Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, Techstars Corporate Innovation Partnerships, and the Techstars Venture Capital Fund. Techstars portfolio includes more than 1,300 companies with a market cap of $12 billion. www.techstars.com
Geniecast is transforming the way the world connects people, ideas, and inspiration. We are curators, producers, and distributors of the world's largest online marketplace of thought leaders, athletes, speakers, celebrities, facilitators and more - all available via two-way, live video broadcast. Join us in the quest to inspire, lead, and evolve. At Geniecast, we strive to offer human-centric client services through great people and clever technology, one transaction at a time. From a warm welcome to individualized attention, we engage with you, one connection at a time. And, when you least expect it, we plan to surprise you with an extra touch, one experience at a time. To learn more, visit https://geniecast.com/.
Emplify, the industry leader in data-driven employee analytics and action-enabling insights for business leaders, helps executives leverage employee insights to make their workforce more successful. Backed by decades of research in human psychology and neuroscience, Emplify InsightsTM blends employee engagement best practices and hands-on expert coaching into an agile feedback system that's simple yet more effective than historic annual employee surveys, and more trustworthy than modern pulse surveys. Emplify is trusted by companies like Ivy Tech Community College, Herff Jones, Harley Davidson, Cheetah Digital, Crew Carwash, Yamaha, and many others. Learn more at emplify.com.
Forty-five minutes from the nearest stoplight, at the end of a incredibly beautiful box canyon sits Telluride, Colorado, a National Historic Landmark surrounded by the highest concentration of 13,000' and 14,000' peaks in the United States. Above Telluride is a modern mountain village connected by a gondola, the only one of its kind in North America. While the ski terrain is world-renowned, the resort is truly defined by a collection of intimate and unmatched experiences. With your first walk down the historic main street, you'll find the character and charm of Telluride as special as the majestic San Juan Mountains. To learn more, visit www.tellurideskiresort.com .
Office: +1 972 629 7305 (United States)
Mobile: +1 972 207 4298
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YPO via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Partnership Between Zaiput Flow Technologies and ThalesNano Set to Improve Process Intensification18.10.2018 15:21 | Pressemelding
BUDAPEST, Hungary and WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zaiput Flow Technologies, a global leader in separation, and ThalesNano, the world leader in bench-top flow chemistry reactors, recently signed a distribution agreement and entered into a technology partnership that exploits the benefits of their combined technologies. Under the distribution Zaiput liquid-liquid phase separators and back pressure regulators are available via ThalesNano in Europe and a number of other countries on a non-exclusive basis, either separately or as part of a bundled offering with ThalesNano’s own microflow reactors. Within the framework of the technology partnership the companies will collaborate to promote adoption of the combined use of their technologies. “We are very excited to work with ThalesNano to offer better-integrated flow chemistry systems to our customers and streamline the work of both novice and experienced users in the flow chemistry space,” said Zaiput CEO, Dr. Andrea Ad
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer18.10.2018 14:03 | Pressemelding
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer. As a result, former Chief Medical Officer Juan Ruiz, M.D., Ph.D. will assume the role of Head of European Medical Affairs. The Company also announced the appointment of Neena Patil, J.D. as General Counsel and Corporate Secretary. Both Dr. Siffert and Ms. Patil report to Chief Executive Officer, Carsten Thiel, Ph.D. “I am very pleased to welcome João and Neena to Abeona, and confident in their abilities to make important contributions to the future growth of our company,” said Dr. Thiel. “João has an ideal blend of clinical, scientific, and regulatory experience to reference as we look to advance our clinical and pre-clinical can
Meltwater and Dow Jones Announce Global Partnership to Provide Premium Content18.10.2018 14:00 | Pressemelding
SAN FRANCISCO and NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Meltwater, a global leader in media intelligence, today announces the launch of a partnership with Dow Jones, a global provider of news and business information, to provide premium licensed content from Dow Jones Factiva into the Meltwater Media Intelligence platform. This partnership will give Meltwater’s PR and communications clients the ability to monitor and analyze premium licensed content across thousands of Factiva news sources globally, including: The Wall Street Journal, America’s largest newspaper by paid circulation; Barron’s; MarketWatch; and Dow Jones Newswires. “Meltwater provides our clients with the most comprehensive content network globally, across news, social media and broadcast media. This new Dow Jones partnership will further strengthen our leadership position and allow our clients to access licensed content from some of the most highly-respected news outlets in the world. We’re excited about this part
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting18.10.2018 13:30 | Pressemelding
EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster session. Data to be presented across the Alzheimer’s disease clinical development portfolio, including aducanumab, BAN2401 and elenbecestat CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in Barcelona, Spain (October 24-27). The data being presented are part of Biogen’s ongoing research programs targeting possible causes of the disease through multiple modalities. “We are excited to engage with the scientific community at CTAD, to share learnings from our Alzheimer’s disease clinical research and to learn from the work of our colleagues around the world. We have hopes that our
SEMAFO Provides Notice of Third Quarter 2018 Results Release and Conference Call 18.10.2018 13:30 | Pressemelding
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- SEMAFO (TSX, OMX: SMF) invites you to participate in a conference call on November 7, 2018 at 10:00 AM EST with senior management during which they will review the Corporation's third quarter 2018 financial and operational results. SEMAFO's financial statements and management's discussion and analysis for the third quarter 2018 will be released on November 6 after market hours and will be available in the “Investor Relations” section of the Corporation's website at www.semafo.com , and on the Canadian Securities Administrators' website at www.sedar.com . A live audio webcast of the conference call will be accessible for a period of 30 days through SEMAFO’s website at www.semafo.com . Tel. local & overseas: +1 (647) 788 4922 Tel. North America: 1 (877) 223 4471 Webcast: www.semafo.com Replay overseas: +1 (416) 621 4642 Replay N. America: 1 (800) 585 8367 Replay pass code: 2823689 Expiration: December 7, 2018 About SEMAFO SEMAFO is a Canadian-b
Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA18.10.2018 13:30 | Pressemelding
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- (CSE: BIO) – Biome Grow (“Biome” or the “Company”) (CSE:BIO) is pleased to announce that the Company’s common shares have been listed on the Frankfurt Stock Exchange under the trading symbol “6OTA”. The Company’s common shares continue to be listed on the Canadian Securities Exchange (“CSE”) under the trading symbol “BIO”. “Biome is developing its production base in Canada with an eye to becoming a leader in the international medical cannabis market. Listing on the Frankfurt Stock Exchange will give Biome increased access to European and other international investors and positions Biome well for international growth and development opportunities,” said CEO Khurram Malik. The Frankfurt Stock Exchange is one of the world’s largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany’s seven stock exchanges and it is an international trading centre, which is reflected in the structure of its
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom